BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9749579)

  • 1. Mitochondria in the etiology and pathogenesis of Parkinson's disease.
    Schapira AH; Gu M; Taanman JW; Tabrizi SJ; Seaton T; Cleeter M; Cooper JM
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S89-98. PubMed ID: 9749579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease.
    Gu M; Cooper JM; Taanman JW; Schapira AH
    Ann Neurol; 1998 Aug; 44(2):177-86. PubMed ID: 9708539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction in neurodegenerative disorders.
    Schapira AH
    Biochim Biophys Acta; 1998 Aug; 1366(1-2):225-33. PubMed ID: 9714816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA in focal dystonia: a cybrid analysis.
    Tabrizi SJ; Cooper JM; Schapira AH
    Ann Neurol; 1998 Aug; 44(2):258-61. PubMed ID: 9708550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal.
    Schapira AH
    Mov Disord; 1994 Mar; 9(2):125-38. PubMed ID: 8196673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group.
    Schapira AH; Mann VM; Cooper JM; Krige D; Jenner PJ; Marsden CD
    Ann Neurol; 1992; 32 Suppl():S116-24. PubMed ID: 1510369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease.
    Ghosh SS; Swerdlow RH; Miller SW; Sheeman B; Parker WD; Davis RE
    Ann N Y Acad Sci; 1999; 893():176-91. PubMed ID: 10672237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary abnormalities of mitochondrial DNA associated with neurodegeneration.
    Tabrizi SJ; Schapira AH
    Biochem Soc Symp; 1999; 66():99-110. PubMed ID: 10989661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family.
    Swerdlow RH; Parks JK; Davis JN; Cassarino DS; Trimmer PA; Currie LJ; Dougherty J; Bridges WS; Bennett JP; Wooten GF; Parker WD
    Ann Neurol; 1998 Dec; 44(6):873-81. PubMed ID: 9851431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic transfer of platelet mtDNA from elderly patients with Parkinson's disease to mtDNA-less HeLa cells restores complete mitochondrial respiratory function.
    Aomi Y; Chen CS; Nakada K; Ito S; Isobe K; Murakami H; Kuno SY; Tawata M; Matsuoka R; Mizusawa H; Hayashi JI
    Biochem Biophys Res Commun; 2001 Jan; 280(1):265-73. PubMed ID: 11162509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson's disease by highlighting the use of cybrid models.
    Lang M; Grünewald A; Pramstaller PP; Hicks AA; Pichler I
    Cell Mol Life Sci; 2022 May; 79(5):283. PubMed ID: 35513611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin and functional consequences of the complex I defect in Parkinson's disease.
    Swerdlow RH; Parks JK; Miller SW; Tuttle JB; Trimmer PA; Sheehan JP; Bennett JP; Davis RE; Parker WD
    Ann Neurol; 1996 Oct; 40(4):663-71. PubMed ID: 8871587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction in Parkinson's disease.
    Mizuno Y; Yoshino H; Ikebe S; Hattori N; Kobayashi T; Shimoda-Matsubayashi S; Matsumine H; Kondo T
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S99-109. PubMed ID: 9749580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA and Parkinson's disease.
    Di Monte DA
    Neurology; 1991 May; 41(5 Suppl 2):38-42; discussion 42-3. PubMed ID: 1904141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson's subject mitochondrial transfer.
    Esteves AR; Lu J; Rodova M; Onyango I; Lezi E; Dubinsky R; Lyons KE; Pahwa R; Burns JM; Cardoso SM; Swerdlow RH
    J Neurochem; 2010 May; 113(3):674-82. PubMed ID: 20132468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 'common deletion' is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction.
    Kösel S; Egensperger R; Schnopp NM; Graeber MB
    Mov Disord; 1997 Sep; 12(5):639-45. PubMed ID: 9380043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects.
    Swerdlow RH; Parks JK; Cassarino DS; Binder DR; Bennett JP; Di Iorio G; Golbe LI; Parker WD
    Exp Neurol; 2001 Jun; 169(2):479-85. PubMed ID: 11358461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mitochondrial etiology of neurodegenerative diseases: evidence from Parkinson's disease.
    Khusnutdinova E; Gilyazova I; Ruiz-Pesini E; Derbeneva O; Khusainova R; Khidiyatova I; Magzhanov R; Wallace DC
    Ann N Y Acad Sci; 2008 Dec; 1147():1-20. PubMed ID: 19076426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model.
    Keeney PM; Quigley CK; Dunham LD; Papageorge CM; Iyer S; Thomas RR; Schwarz KM; Trimmer PA; Khan SM; Portell FR; Bergquist KE; Bennett JP
    Hum Gene Ther; 2009 Aug; 20(8):897-907. PubMed ID: 19374590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Genes Associated with Mitochondrial DNA Processes as Contributors to Parkinson's Disease Risk.
    Müller-Nedebock AC; van der Westhuizen FH; Kõks S; Bardien S
    Mov Disord; 2021 Apr; 36(4):815-831. PubMed ID: 33513296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.